Skip to main content
Have a personal or library account? Click to login
Simulated Microgravity Reduces Growth but Preserves Bone-Relevant Bioactivity of Medicago truncatula Cover

Simulated Microgravity Reduces Growth but Preserves Bone-Relevant Bioactivity of Medicago truncatula

By:  and    
Open Access
|Jun 2026

Figures & Tables

Figure 1.

Two-dimensional clinostat system positioned with a controlled environment chamber (EGC M-48, Environmental Growth Chamber, Chagrin Falls, OH, USA). M. truncatula seeds were placed at the center of each petri dish containing Murashge and Skoog (MS) medium and mounted on the rotating clinostat plate to simulate microgravity conditions, while identical controls were maintained within the same chamber (foreground) under identical environmental conditions.

Figure 2.

Effects of simulated microgravity on growth of M. truncatula growth parameters after 14 days. The data represent (A) shoot fresh mass, (B) shoot length, (C) primary root length, and (D) number of lateral roots under stationary 1g or clinorotation (simulated μg) conditions. Data represent the mean of three independent experiments (10 seedlings per experiment). Error bars indicate standard deviation. Asterisks denote statistically significant differences (p ≤ 0.001) between 1g and simulated μg treatments.

Table 1.

RAW264.7 metabolic activity expressed as percentage of 0.1% ethanol control following exposure to Medicago truncatula extracts under static and clinostat conditions.

StaticClinostat
Ethanol controls
Dose (%)% ControlSDDose (%)% ControlSD
0.11003.70.11003.8
M. truncatula extracts
StaticClinostat
Dose (ng)*% ControlSDDose (ng)% ControlSD
4.9581.45.456.61.2
9.853.23.510.754.32.6
14.752.32.616.551.87.2
1951.84.421.440.21.6

x Dose is ng, as coumestrol equivalents.

y Values are mean ± SD, normalized to the 0.1% ethanol control.

Figure 3.

Effects of simulated microgravity on M. truncatula secondary metabolite concentrations after 14 days. The data represents (A) total flavonoid concentration (mg g−1 fresh mass) as quercetin equivalents and (B) total isoflavonoid concentration (mg g−1 fresh mass) as genistein equivalents. Data represent the mean of three independent experiments (10 seedlings per experiment). Error bars indicate standard deviation. Asterisks denote statistically significant differences (p ≤ 0.05) between 1g and simulated μg treatments.

Table 2.

Summary of metabolic effects of Medicago truncatula ethanol extracts on bone-relevant cell models.

Cell LineCell type/functionEnd point assessedObserved effectx
MC3T3-E1osteoblast-likeCell Proliferation (cell counts)No detectable effect
MC3T3-E1osteoblast-likeAlkaline phosphatase activityNo detectable effect
RAW264.7osteoclast precursoryCell Proliferation (cell counts)↓40–60 % relative to EtOH control

x Effects are based on cell counts for proliferation assays and alkaline phosphatase activity for MC3T3-E1 cells, normalized to ethanol vehicle controls.

y RAW264.7 cells are commonly used as an osteoclast precursor model but were not induced to terminal differentiation in this study.

Figure 4.

RAW264.7 activity in response to the 0.1% ethanol extracts from 14-day-old M. truncatula seedlings that have been grown under static or 2-D clinostat conditions.

Figure S1.

Representative morphology of M. truncatula seedlings grown for 14 days under (A) stationary 1g conditions and (B) 2-D clinostat-modeled simulated microgravity. Seedlings grown under microgravity exhibited reduced shoot length, primary root length, lateral root development and overall biomass reduction relative to 1g controls.

Table S1.

MC3T3-E1 metabolic activity expressed as percent of 0.1% ethanol control following exposure to Medicago truncatula extracts under static and clinostat conditions.

Treatment
StaticClinostat
Ethanol controls
Dose (%)% ControlSDDose (%)% ControlSD
0.11007.80.11008.3
M. truncatula extracts
StaticClinostat
Dose (ng)*% ControlSDDose (ng)% ControlSD
4.986.14.25.497.82.5
9.894.48.310.797.22.8
14.797.26.916.596.78.9
1995.88.321.495.88.3

x Dose is ng, as coumestrol equivalents.

y Values are mean ± SD, normalized to the 0.1% ethanol control.

Table S2.

Alkaline phosphatase (ALP) metabolic activity expressed as percent of 0.1% ethanol control following exposure to Medicago truncatula extracts under static and clinostat conditions.

Treatment
StaticClinostat
Ethanol controls
Dose (%)% ControlSDDose (%)% ControlSD
0.11007.20.11007.3
M. truncatula extracts
StaticClinostat
Dose (ng)*% ControlSDDose (ng)% ControlSD
4.996.47.55.496.87.6
9.898.27.410.796.87.4
14.796.87.516.598.27.5
1997.37.421.495.57.3

x Dose is ng, as coumestrol equivalents.

y Values are mean ± SD, normalized to the 0.1% ethanol control.

Language: English
Page range: 7 - 19
Published on: Jun 12, 2026
Published by: American Society for Gravitational and Space Research
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2026 Gary W. Stutte, Adam Shinners, published by American Society for Gravitational and Space Research
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.